XML 25 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 25, 2016
Dec. 27, 2015
Dec. 28, 2014
Cash flows from operating activities:      
Net earnings including noncontrolling interest $ 94,213 $ 94,876 $ 94,055
Adjustments to reconcile net earnings to cash provided by operations:      
Depreciation and amortization 152,140 127,503 98,454
Loss on asset disposals and impairment 8,434 7,462 3,827
Deferred lease credits 4,284 4,052 4,331
Deferred income taxes (2,138) (281) (3,946)
Stock-based compensation 325 13,647 14,253
Excess tax benefit from stock issuance (204) (5,455) (2,500)
Change in fair value of contingent consideration (3,691) 0 0
Loss on investments in affiliates 2,805 687 0
Provision for bad debt expense 226 0 0
Change in operating assets and liabilities, net of effect of acquisitions:      
Trading securities 0 (495) (972)
Accounts receivable 4,358 (4,313) (3,443)
Inventory (1,148) (2,407) (2,178)
Prepaid expenses (2,677) (691) 383
Other assets (7,778) (6,381) (139)
Deferred revenue 945 100 191
Accounts payable 4,462 4,445 5,343
Income taxes 20,777 (6,356) (2,948)
Accrued expenses 7,256 10,867 13,155
Net cash provided by operating activities 282,589 237,260 217,866
Cash flows from investing activities:      
Acquisition of property and equipment (141,699) (172,548) (137,466)
Acquisition of businesses/investments in affiliates (3,862) (203,642) (30,572)
Purchase of marketable securities (488) (12,301) (22,991)
Proceeds from sale of marketable securities 1,205 23,300 12,000
Net cash used in investing activities (144,844) (365,191) (179,029)
Cash flows from financing activities:      
Proceeds from revolving credit facility 668,377 352,678 0
Repayments of revolving credit facility (532,907) (318,148) 0
Borrowings from restricted funds 6,365 36,179 0
Repurchases of common stock (232,696) (25,000) 0
Other financing activities (3,901) (3,173) 0
Issuance of common stock 4,209 5,355 3,032
Excess tax benefit from stock issuance 204 5,455 2,500
Tax payments for restricted stock units (9,317) (7,847) (7,474)
Net cash provided by (used in) financing activities (99,666) 45,499 (1,942)
Effect of exchange rate changes on cash and cash equivalents (33) 323 (1,068)
Net increase (decrease) in cash and cash equivalents 38,046 (82,109) 35,827
Cash and cash equivalents at beginning of year 11,220 93,329 57,502
Cash and cash equivalents at end of year $ 49,266 $ 11,220 $ 93,329